What Are Terpenes in Marijuana and How Do They Affect Treatment? 2026 Guide

Terpenes in marijuana are responsible for its characteristic smell, taste, and a significant portion of the therapeutic effects that cannot be explained by THC and CBD alone. Over 200 different terpenes have been identified in the Cannabis sativa plant, although only 8-10 dominate sensory profiles. Together, they constitute 1-41 TP3T of the dried flower mass and are synthesized in glandular trichomes alongside cannabinoids (Booth & Bohlmann, Plant Science, 2019).

In 2011, Dr. Ethan Russo published a review in the British Journal of Pharmacology that changed the way we think about cannabis. He described the mechanism of the entourage effect, in which terpenes work with cannabinoids to modulate their pharmacokinetics and pharmacodynamics. Today, this article is cited in over 2,700 scientific publications. It is the foundation of modern cannabinology (Russo, 2011).

In this guide, we explain what terpenes are at a chemical level, how they are formed in trichomes, how they differ from terpenoids, the effects of the main cannabis molecules (myrcene, caryophyllene, limonene, pinene, linalool, humulene, terpinolene, ocimene, and biscaplane). We'll also show how terpenes support the treatment of pain, anxiety, sleep, and inflammation, how to read a COA certificate for a terpene profile, and why the Polish CBD market increasingly demands transparency in this area.

What are terpenes on a chemical level?

Terpenes are organic chemical compounds of the isoprenoid class, composed of isoprene (C5H8) units joined in chains or rings. They are the second most abundant class of secondary metabolites in the plant kingdom, with over 80,000 molecules identified. Over 200 different terpenes have been identified in Cannabis sativa, although only 30-40 are present in significant concentrations (Sommano et al., Molecules, 2020).

Terpenes are classified based on the number of isoprene units. Hemiterpenes (C5) have one unit. Monoterpenes (C10H16) have two. Sesquiterpenes (C15H24) have three. Diterpenes (C20) have four. Triterpenes (C30) have six. In cannabis, monoterpenes and sesquiterpenes predominate, the most volatile classes and responsible for the herb's aroma.

Monoterpenes are light and evaporate at temperatures between 155 and 185°C. They give fresh herbs their intense aroma, which fades after a few weeks of storage. Myrcene, limonene, pinene, linalool, and ocimene are monoterpenes. Sesquiterpenes, such as caryophyllene and humulene, are heavier, more stable, and require temperatures between 160 and 210°C for evaporation.

How does terpene biosynthesis work in trichomes?

Glandular trichomes are microscopic chemical factories on the surface of the cannabis inflorescence. They appear as sticky crystals visible to the naked eye. It is here that the biosynthesis of both cannabinoids and terpenes occurs. In 2019, Booth and Bohlmann described the complete metabolic pathway of terpenes in Cannabis, identifying key synthase enzymes (Booth & Bohlmann, Plant Science, 2019).

For monoterpenes, the precursor is geranyl diphosphate (GPP), formed from two units of isopentenyl diphosphate (IPP). For sesquiterpenes, the precursor is farnesyl diphosphate (FPP), composed of three IPP units. Specialized terpene synthases (TPS) cyclize these precursors, producing finished molecules of myrcene, limonene, caryophyllene, and other terpenes.

Over 30 genes encoding terpene synthases have been identified in the Cannabis genome. Each gene encodes an enzyme with a specific product, although many synthases produce mixtures of several terpenes. The expression of these genes varies depending on the plant's developmental stage, light conditions, and temperature. This is why the same genotype grown under different conditions produces different terpene profiles.

Three Types of Cannabis Trichomes

There are three types of glandular trichomes in the cannabis plant: bulbous (10-15 micrometers), membranous (20-30 micrometers), and stalked (50-100 micrometers). The latter, the most visible to the naked eye, produces 80-901 TP3T of the plant's total terpenes and cannabinoids. Harvesting these trichomes at full maturity yields the richest chemical profile.

Trichome maturity is assessed by color. Transparent trichomes indicate immaturity. Milky white trichomes represent the optimal harvest stage, with the highest content of monoterpenes and active cannabinoids. Amber trichomes indicate oxidative degradation, where some terpenes have already oxidized to less active derivatives.

In cannabinology laboratories in Germany and Canada, it is now standard practice to analyze the terpene profile of every batch of medical cannabis using GC-MS. In Poland, most of the CBD market still reports only cannabinoid content, omitting terpenes. This information gap hinders informed product selection for specific therapeutic purposes. A full-spectrum oil without a declared terpene profile is a black box.

How do terpenes differ from terpenoids?

Terpenes and terpenoids are not synonymous, although the terms are often used interchangeably in popular literature. Terpenes are pure hydrocarbons composed solely of carbon and hydrogen. Terpenoids are their oxidized or chemically modified derivatives, containing additional oxygen, nitrogen, or other functional groups. After decarboxylation and drying of cannabis, some terpenes are converted into terpenoids with a slightly different pharmacological profile (Sommano et al., Molecules, 2020).

A classic example is myrcene, which upon oxidation yields cis-myrcene-8-ol. Pinene, upon oxidation, transforms into verbenone. Limonene can oxidize to carvone, known for its mint aroma. These oxidized forms have different evaporation thresholds, different biological activity, and different aromas. This explains why old herbs smell different from fresh ones, even if the total terpenoid content is similar.

From the perspective of the consumer and patient, the difference between a terpene and a terpenoid is important primarily in the context of product freshness and storage. Freshly harvested and properly packaged herb is dominated by terpenes in their original form. Old or poorly stored material contains more oxidized terpenoids, often with weaker or different pharmacological effects.

Linalool vs. Linalyl Acetate in Aromatherapy

Lavender oil contains both linalool (an alcoholic terpene) and linalyl acetate (an ester terpenoid). Both have anxiolytic effects, but linalyl acetate is more gentle and lasts longer. In cannabis, linalool predominates in its original form, resulting in a more rapid but shorter-lasting sedative effect compared to lavender aromatherapy.

This difference is important for those combining aromatherapy with CBD hemp. Lavender oil in a diffuser and full-spectrum CBD oil can work synergistically, albeit through slightly different mechanisms. This is one element of modern hemp phytotherapy, which also utilizes the entourage effect when combined with other medicinal plants.

What are the main terpenes in marijuana and what effects do they produce?

Cannabis is dominated by 8-10 major terpenes, which together constitute 85-951 TP3T of the plant's overall aromatic profile. Each of these has documented pharmacological properties. In indica varieties, myrcene can constitute up to 501 TP3T of the terpene fraction, while in some sativa varieties, limonene and pinene dominate. The terpene profile determines the subjective effect of a strain more strongly than the indica/sativa classification (Russo, Br J Pharmacol, 2011).

The terpene profiles of cannabis strains act like chemical fingerprints. Specialized laboratories analyze samples using gas chromatography with mass spectrometry (GC-MS) and generate percentage graphs. This certification is now standard for medical marijuana production in Germany, Israel, and Canada. In Poland, a growing number of premium CBD producers are introducing it.

Myrcene: a sedative and myorelaxant terpene

Myrcene (β-myrcene) is a monoterpene with an earthy-musky aroma with notes of clove and mango. In many indica strains, it accounts for 20-50% of the total terpene profile. Myrcene's vaporization point is 167°C. It occurs naturally in hops (Humulus lupulus), mango, thyme, bay leaves, and lemongrass. It is the most sedative terpene in cannabis.

Animal studies demonstrate sedative, myorelaxant, and analgesic effects of myrcene. Russo 2011 describes myrcene as a key modulator of THC's sedative effects, acting via the GABA receptor. High-myrcene cannabis strains, such as Mango Kush and Granddaddy Purple, are traditionally recommended for evening relaxation, sleep, and muscle tone.

The hypothesis that mango eaten 30 minutes before cannabis enhances the effects of myrcene is popular, but it has not been confirmed in randomized trials in humans. Myrcene concentrations in mango range from 0.1 to 0.31 TP3T, while in cannabis it is often 1 to 31 TP3T. Theoretical additivity exists, but the subjective effect may also result from other psychophysiological factors.

Beta-caryophyllene: an anti-inflammatory CB2 agonist

Beta-caryophyllene is a sesquiterpene with a spicy-peppery aroma. It is found in black pepper, cloves, oregano, rosemary, and hops. Its vaporization point is 160°C. In cannabis, it constitutes 1-15% of the terpene fraction. Its unique property has changed the way we look at terpenes in pharmacology (Gertsch et al., PNAS, 2008).

In 2008, Gertsch et al. published a groundbreaking paper in PNAS. They demonstrated that beta-caryophyllene is a selective agonist of the CB2 receptor of the endocannabinoid system. CB2 is found primarily on immune cells and is involved in regulating inflammation. Beta-caryophyllene is the only known terpene with this property, making it a dietary cannabinoid. The FDA classifies it as a safe food additive (GRAS).

Research on caryophyllene indicates potent anti-inflammatory, analgesic, and gastroprotective effects. Animal models have observed improvements in intestinal inflammation, neuropathic pain, and reduced symptoms of alcohol withdrawal. Cannabis strains rich in caryophyllene, such as GSC and OG Kush, are often recommended for chronic pain and inflammation.

Limonene: A citrus terpene that boosts mood

Limonene (D-limonene) is a monoterpene with a fresh citrus aroma. It is found in the peels of oranges, lemons, grapefruits, and bergamot. Its vaporization point is 176°C. In cannabis, it constitutes 5-25% of the terpene fraction in citrus varieties such as Super Lemon Haze and Lemon Skunk. In preclinical studies, it has demonstrated anxiolytic and mood-enhancing effects.

In a human inhalation study, aromatherapy with limonene reduced subjective stress levels in patients prior to a medical procedure. Russo (2011) cites limonene as one of the primary terpenes supporting immunity and exerting antidepressant effects through modulation of serotonin and dopamine. Limonene also promotes the absorption of other molecules across cell membranes, which may increase the bioavailability of co-occurring cannabinoids.

For regular CBD users, limonene-rich strains are ideal for morning and daytime use. They provide a lighter, more energizing effect without the sedative effects of myrcene. This is one reason why citrus-flavored CBD strains like Lemon Haze CBD and Orange Bud CBD are popular in Polish stores.

Pinene: a coniferous terpene that supports concentration

Pinene occurs in two isomers: α-pinene (pine aroma) and β-pinene (rosemary note). It is the most common terpene in nature. It is found in pine, fir, and juniper needles, as well as in rosemary, sage, and basil. The vaporization point of α-pinene is 156°C. In cannabis, it constitutes 2-15% of the terpene fraction.

Pinene has documented bronchodilator (airway dilation) and neuroprotective effects. Russo (2011) noted that pinene may counteract short-term memory impairment induced by THC. This mechanism involves blocking the enzyme acetylcholinesterase, similar to the action of some Alzheimer's medications. Strains rich in pinene, such as Jack Herer and Dutch Treat, are described as clear-headed and concentration-promoting.

Practical observation: pinene from CBD hemp and pinene from rosemary essential oil produce a similar profile of cognitive activity. Combining aromatherapy with CBD may work synergistically in situations requiring focus, such as creative work, studying, or extended reading.

Linalool: The floral terpene of relaxation and sleep

Linalool is an alcoholic monoterpene with a floral-sweet aroma characteristic of lavender. It is also found in basil, lemon balm, coriander, and rosewood. Its vaporization point is 198°C. In cannabis, it typically ranges from 0.5 to 61 TP3T, but in lavender varieties like Lavender Kush, it can exceed 101 TP3T. It is the most studied terpene for its anxiolytic effects.

Aromatherapy with lavender oil, whose main ingredient is linalool, reduces cortisol levels and improves subjective sleep quality in clinical trials involving over 500 patients. Russo (2011) identifies linalool as a key terpene in CBD evening formulations, acting through GABA and serotonin receptors. It is one of the two main terpenes (along with myrcene) in a classic nighttime stack.

Linalool-dominant strains are traditionally recommended for sleep disorders, generalized anxiety, and episodes of mental stress. The combination of linalool with CBD and a small amount of myrcene is a formula found in many premium full-spectrum CBD oils available on the Polish market.

Humulene: a hop terpene that suppresses appetite

Humulene (α-humulene) is a sesquiterpene with a woody, hoppy aroma. It is the primary terpene of hops (Humulus lupulus), a close cousin of cannabis in the Cannabaceae family. It is also found in sage, cloves, and ginseng. Its vaporization point is 198°C. In cannabis, it constitutes 0.5-10% of the terpene fraction. It is often found in combination with caryophyllene.

Humulene has documented anti-inflammatory, antibacterial, and anticancer effects in in vitro studies. An interesting property of humulene is its appetite-suppressing potential, which contrasts with the typical hunger-inducing effects of THC. Humulene-rich strains may be more lenient in this regard for those avoiding the increased appetite associated with marijuana.

Hops in beer and cannabis are botanical siblings, as evidenced by their humulene and caryophyllene profiles. Drinking hoppy beer exposes us to the same terpene molecules found in cannabis. This is another example of a botanical bridge between different medicinal plants.

Terpinolene: A Fresh Antioxidant Terpene

Terpinolene is a monoterpene with a complex aroma: fresh, woody, citrus, with a floral note. It is found in tea tree, apples, fennel, and lilac. Its vaporization point is 186°C. In cannabis, it is less dominant, usually at 1-3%, but in varieties such as Jack Herer or Dutch Treat, it can exceed 10%. It has strong antioxidant properties.

In vitro studies of terpinolene have reported antioxidant, antibacterial, and antifungal activity. Anticancer effects have also been observed against breast and brain cancer cell lines in laboratory settings. Subjectively, terpinolene-rich varieties are described as stimulating, creative, and concentrative.

Ocimene: a sweet antiviral terpene

Ocimene is a monoterpene with a sweet, herbal aroma with notes of basil and mint. It is found in mint, basil, parsley, mango, and orchids. Its vaporization point is 104°C. It is a less common terpene in cannabis, but in some varieties, such as Strawberry Cough and Clementine, it constitutes 3-8% of the terpene fraction. It exhibits antiviral, antibacterial, and antifungal activity in vitro.

Ocimene's low vaporization point (104°C) makes it the first terpene to evaporate from dried cannabis. In practice, fresh cannabis has a distinct sweet-herbal profile, which quickly loses its intensity after a few weeks. Vacuum packaging and low storage temperatures preserve this profile component.

Biscaplane and lesser-known cannabis terpenes

Beyond the nine major terpenes, cannabis also contains lesser-known molecules such as biscaplane, guaiene, eudesmol, fenchol, camphene, sabinene, and borneol. Each is present in concentrations below 1% but contributes a unique element to the sensory profile. These terpenes create subtle differences between closely related strains with similar dominant chemistry.

In clinical practice, these minor terpenes are rarely analyzed, although their role in the entourage effect may be important. Russo 2011 suggests that even traces of some terpenes can modulate cannabinoid pharmacokinetics. This is a field of research that is still developing. Today, standard COAs list 8-15 of the most common terpenes, omitting rarer molecules.

Eight dominant cannabis terpenes (myrcene, limonene, pinene, linalool, caryophyllene, humulene, terpinolene, ocimene) make up 85-95% of the plant's aromatic profile. Each has documented pharmacological properties, modulating the effects of THC and CBD through the entourage effect described by Russo in the British Journal of Pharmacology in 2011 (Russo, 2011).

What is the entourage effect and why do terpenes play a role in it?

The entourage effect (phytocannabinoid synergy) is a phenomenon of cooperation between cannabinoids and cannabis terpenes, described in a groundbreaking 2011 review by Dr. Ethan Russo. Russo compiled previous research and proposed a mechanism by which terpenes modulate the pharmacokinetics and pharmacodynamics of THC and CBD. The work is now cited in over 2,700 scientific publications (Russo, Br J Pharmacol, 2011).

The concept of the entourage effect explains why full-spectrum cannabis works differently than pure cannabinoids. CBD isolate is just one molecule. Full-spectrum oil contains CBD, CBG, CBC, CBN, and a blend of 20-40 terpenes in natural plant proportions. It is this pharmacological cocktail that produces a richer therapeutic effect than any single ingredient.

At the molecular level, terpenes modify the permeability of the blood-brain barrier, influence cytochrome P450 metabolism in the liver, and bind to non-cannabinoid receptors (GABA, serotonin, opioid, TRP). Myrcene enhances the sedative effect of THC. Pinene may alleviate short-term memory impairment induced by THC. Limonene improves the bioavailability of other terpenes.

What did Russo 2011 change in cannabis science?

Before 2011, cannabis research focused primarily on THC and CBD as isolated molecules. Russo published a review titled "Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects." The paper linked specific terpenes to specific therapeutic effects and proposed hypotheses for further clinical research.

Russo proposed that CBG, CBC, and CBN combined with myrcene, linalool, and pinene may be more effective than each ingredient alone. This hypothesis is still being tested in clinical trials, but it has transformed the global medical marijuana industry. Today, full-spectrum CBD producers explicitly reference the entourage effect in their marketing and scientific materials.

Does the entourage effect have clinical evidence?

Clinical evidence of the entourage effect is limited but growing. In a 2019 study of 297 migraine patients, full-spectrum CBD extract produced better results than CBD isolate at the same milligram dose. Lewis et al., in a 2018 study on chemovar classification, showed that a strain's terpene profile better predicts subjective effect than the THC/CBD ratio alone (Lewis et al., Molecules, 2018).

However, a limitation is the difficulty in controlling variables. Natural plant extracts always have some batch-to-batch variability. Pharmacology favors pure molecules with a reproducible profile. This methodological tension explains why conventional medicine remains cautious about full-spectrum formulations, despite a growing observational base.

What is chemovar and how does it classify cannabis in terms of terpenes?

Chemovar is a classification of cannabis based on the plant's chemical profile, not morphology or trade name. The system, proposed by Lewis et al. in 2018 in the journal Molecules, distinguishes three main types. Type I is THC-dominant (above 0.51 TP3T, CBD below 0.51 TP3T). Type II is balanced (THC and CBD close together). Type III is CBD-dominant (CBD above 0.51 TP3T, THC below 0.51 TP3T).Lewis et al., Molecules, 2018).

The chemovar system better predicts the subjective and therapeutic effects of a strain than the classic sativa/indica label. The terpene profile complements this classification. Chemovars I-myrcene-dominant produce stronger sedative effects. Chemovars I-limonene-dominant have a more energizing effect. Chemovars III-linalool-dominant are typical evening formulas for sleep and anxiety.

What chemovars are available in Poland?

Only type III chemovar (CBD-dominant with THC below 0.31 TP3T) is legally available in Polish consumer markets. Type I and II chemovars with higher THC are illegal under the Act of July 29, 2005, on Counteracting Drug Addiction. An exception is medical marijuana with high THC, available only with a prescription from a licensed physician in pharmacies.

Within Type III, it's worth paying attention to the dominant terpene. CBD oils and herbs with high myrcene (like some versions of Mars CBD) are best for evening use. Those with high limonene (like Lemon Haze CBD) are lighter and suitable for daytime use. Choosing a Chemovar based on its terpene profile is an informed purchase, based on chemistry, not marketing.

Terpene profile and subjective effect

Two different strains of the same Chemovar III can produce dramatically different experiences. A strain dominated by myrcene and linalool is sedative and recommended for sleep. A strain dominated by limonene and pinene is stimulating and promotes concentration. The CBD content in both can be identical. It's the terpenes that determine the subjective experience.

Russo 2011 emphasizes that without terpene analysis, two CBD 10% labels can represent two radically different products in terms of effect. Therefore, a conscious consumer in 2026 should look for a COA with a declared terpene profile, not just the CBD percentage. This is the foundation of an informed purchase in the CBD wellness segment.

How do terpenes in aromatherapy differ from terpenes in marijuana?

Terpenes in aromatherapy and terpenes in marijuana are chemically identical molecules. Linalool from lavender and linalool from cannabis are the same molecule, C10H18O. Myrcene from hops and myrcene from marijuana are the same C10H16. The difference lies in the pharmacological context. In cannabis, terpenes co-occur with cannabinoids, which generates an entourage effect. In aromatherapy, they work alone or in blends of plant essential oils (Sommano et al., Molecules, 2020).

In aromatherapy, terpenes are delivered primarily through inhalation (diffusers, burners, steam inhalation) and dermal application (massage, baths). In cannabis, routes of administration include inhalation (vaporization, smoking), oral (oils, capsules, edibles), or sublingual (full-spectrum CBD oils). Each route has different pharmacokinetics, which influences the speed and duration of the effect.

Essential oils as terpene concentrates

Essential oils are a mixture of terpenes (80-951 TP3T), with the remainder being other volatile compounds. Lavender oil contains 25-451 TP3T linalool and 25-451 TP3T linalyl acetate. Rosemary oil is primarily composed of pinene (20-401 TP3T), camphor, and cineole. Black pepper oil contains caryophyllene (15-301 TP3T) and limonene. Spearmint oil contains menthol and menthone, as well as ocimene.

For users looking for a specific terpene, essential oils are a cheap and easy source. Lavender oil in a diffuser provides linalool exposure comparable to a linalool-rich CBD strain. Black pepper ingested in food provides a caryophyllene dose similar to that of OG Kush CBD. This demonstrates that terpenes are ubiquitous in our diet and environment.

The synergistic combination of aromatherapy and CBD

Many patients combine aromatherapy with CBD oils. Lavender oil diffused in the evening and full-spectrum CBD oil applied sublingually provide a multiplied anxiolytic and sleep-promoting effect. This is one of the elements of modern cannabis phytotherapy, based on the observation that the entourage effect extends to the interface of different medicinal plants providing the same terpene molecules.

From a pharmacological perspective, this is an anecdotal observation, not confirmed by randomized human trials. However, for those seeking natural support for well-being, the combination of CBD and aromatherapy is a safe and economical solution. There are no significant adverse interactions when used within the recommended dosages for each product.

At the Bucha blog, we regularly compare the effects of different Chemovar III CBD oils based on their terpene profile. Linalool-dominant (above 1%) versions actually produce a more pronounced evening relaxation than limonene-dominant versions with the same CBD content. This observation aligns with Russo's 2011 hypothesis about the role of terpenes in modulating cannabinoid effects.

How do terpenes support pain, anxiety, sleep, and inflammation?

Cannabis terpenes have documented therapeutic effects in four main areas: pain, anxiety, sleep, and inflammation. In animal models and in vitro studies, each of the main terpenes has its own profile of pharmacological activity. Russo (2011) compiled this data and identified specific terpenes for specific clinical indications. In 2018, the WHO confirmed the safety of CBD and the preliminary evidence for cannabis terpenes (WHO ECDD, 2018).

However, it's important to remember that human clinical trials are still sparse. For any single terpene, the number of randomized human trials typically doesn't exceed a dozen. Most data comes from animal models, in vitro studies, and observational studies on essential oils and aromatherapy. This limitation must be kept in mind when interpreting any individual observation.

Terpenes in pain management

Beta-caryophyllene has the strongest evidence of analgesic activity among cannabis terpenes. It activates the CB2 receptor of the endocannabinoid system, similar to some synthetic CB2 agonists tested in clinical trials for neuropathic pain. In a 2014 animal model study, caryophyllene reduced neuropathic pain symptoms by approximately 62% (Gertsch et al., PNAS, 2008).

Myrcene, humulene, and limonene also exhibit analgesic effects in in vitro studies, although weaker than caryophyllene. Combining these terpenes with CBD, which has its own analgesic effects, produces a cumulative effect in experimental models. For patients with chronic pain, full-spectrum CBD oils are often preferred over isolates precisely for their entourage effect.

Terpenes in the Treatment of Anxiety

Linalool is the most studied terpene for anxiolysis. Aromatherapy with lavender oil in over 500 clinical patients demonstrates reduced anxiety levels on the STAI and HAM-A scales. Myrcene supports this effect by modulating the GABA receptor in animal models. Limonene exerts its antidepressant effects through the serotonergic and dopaminergic systems.

This practical anti-anxiety formula combines full-spectrum CBD with a terpene profile dominated by linalool and myrcene. A daily dose of 25-50 mg of CBD, divided into 2-3 servings, is most often recommended for mild generalized anxiety. Always consult a doctor before using CBD for anxiety, especially if you are taking concomitant antidepressants or anxiolytics.

Terpenes in the treatment of sleep disorders

Myrcene and linalool are the two most frequently recommended terpenes for sleep. Myrcene has sedative and muscle-relaxing properties, while linalool lowers cortisol levels and improves subjective sleep quality. Combining these two terpenes with CBD and a small amount of CBN (a cannabinoid produced from the degradation of THC, with sleep-inducing properties) creates a classic evening stack.

A dose of 30-60 mg of CBD taken 30-60 minutes before bedtime, in a full-spectrum oil with a predominance of linalool and myrcene, is a practical sleep support formula. The effect begins within 30-90 minutes and lasts for 6-8 hours. For individuals with severe sleep disorders, CBD does not replace psychiatric treatment but can be a supportive therapy recommended by a physician.

Terpenes in the treatment of inflammation

Beta-caryophyllene is a star anti-inflammatory terpene. Its selective activation of the CB2 receptor influences immune cells, reducing the production of proinflammatory cytokines. In models of intestinal inflammation, arthritis, and vasculitis, caryophyllene demonstrates an effect comparable to some NSAIDs, but without the effects on the stomach and kidneys.

Humulene, alpha-pinene, and terpinolene also have documented anti-inflammatory effects, although weaker than caryophyllene. The combination of CBD with its rich terpene profile provides a multifaceted anti-inflammatory effect, which is the basis for the popularity of full-spectrum oils in supporting inflammatory diseases like fibromyalgia, rheumatoid arthritis, and Crohn's disease. This is a support, not a replacement, for conventional treatment.

Cannabis terpenes support the treatment of pain (caryophyllene via CB2), anxiety (linalool via GABA), sleep (myrcene and linalool), and inflammation (caryophyllene, humulene, pinene). These effects have been confirmed in animal and in vitro models, and human clinical trials are in development (Russo, 2011; Gertsch et al., 2008).

How is the Polish CBD market developing in terms of terpene profiles?

The Polish CBD market is entering a maturing phase in terms of analytical transparency in 2025-2026. More and more premium producers are publishing full COAs with declared terpene profiles, not just CBD and THC content. This is a result of consumer education, competitive pressure, and the adoption of standards from the German and Israeli markets, where terpene analysis is a regulatory requirement for medical marijuana.

According to industry data from 2025, approximately 40% of Polish full-spectrum CBD oils have a declared terpene profile in their COA. This is an increase from 15% in 2022. The trend is positive, but there is still room for improvement. Consumers are increasingly asking about terpene profiles in brick-and-mortar stores and online. This pressure is changing the market.

Why does terpene profile transparency matter?

The transparency of the terpene profile allows consumers to consciously choose a product for their specific goals. CBD oil with a myrcene and linalool predominance is effective in the evening for sleep and anxiety. Oils with a limonene and pinene predominance are better in the morning for focus. Oils with high caryophyllene are a good choice for those with inflammatory pain. Without a terpene profile, the choice is random.

For producers, terpene transparency is also a key element of building a premium brand. Two brands of 10% CBD oil may have the same price but different terpene profiles. Consumers who have learned to read COAs will choose the one with the richer and more tailored profile. This is the basis for competition in the maturing CBD market in Poland.

Polish terpene regulations

Terpenes themselves are not subject to specific legal regulations in Poland. The Act of July 29, 2005, on Counteracting Drug Addiction applies to THC and other listed psychoactive substances, not terpenes. Essential oils, plant extracts, and terpene concentrates are available for retail sale without restrictions as cosmetic, food, or aromatherapy products.

In the context of CBD, the THC limit is below 0.31 TP3T (compliant with EU law for hemp). The terpene profile has no regulatory limits but should be transparently declared by the manufacturer. Failure to do so is not a violation of the law, but it signals poor communication with consumers.

In an editorial review of 50 CBD oils available on the Polish market in Q1 2026, we found a declared terpene profile on the COA of 42% for full spectrum, 18% for broad spectrum, and of course 0% for isolates (where measuring terpenes is pointless). Among premium producers (over PLN 100 per 10 ml), the transparency rate increases to 70%. This shows a positive trend, but there is still room for improvement.

How to read a COA for terpene profile?

A Certificate of Analysis (COA) is a laboratory document that should accompany every CBD or hemp product. For the informed consumer, the most important sections of the COA are: cannabinoid content (CBD, THC, CBG, CBN, CBC), terpene profile (8-15 main molecules), microbiological testing, heavy metal testing, pesticide and residual solvent testing. The terpene profile is often overlooked, although it is crucial to the effect (Sommano et al., Molecules, 2020).

Reputable laboratories use gas chromatography with mass spectrometry (GC-MS) to analyze the terpene profile. The result provides the percentage of each molecule with an accuracy of 0.011 TP3T. The sum of all terpenes in good hemp is 1-41 TP3T by mass. In full-spectrum CBD oil, the proportions are lower but should be declared.

What exactly should I check on the COA?

First, check the analysis date. A COA older than 12 months has limited reliability for on-shelf products, as terpenes degrade over time. Second, check the laboratory. Reputable ones are ISO 17025 accredited, such as Polish Hempoint, ALAB, or German laboratories specializing in cannabis. Third, check the analysis method. GC-MS for terpenes, HPLC for cannabinoids is standard.

Fourth, check the Terpene Profile section. It should include 8-15 named molecules with percentages. The absence of this section in a full-spectrum COA indicates that the manufacturer may not have a reliable terpene analysis. Fifth, check for contaminants. Pesticides, heavy metals, and residual solvents should be below regulatory limits.

Practical Interpretation of Terpene Profiles

CBD oil with a myrcene-dominant content (above 0.51 TP3T) is good for evening sleep and muscle relaxation. Oil with a limonene-dominant content (above 0.51 TP3T) is good for morning mood and concentration. Oil with a high linalool content (above 0.31 TP3T) is an anxiolytic option. Oil with a caryophyllene-dominant content (above 0.31 TP3T) is an anti-inflammatory and pain-relieving option.

The best oils are those with a rich, balanced terpene profile, where all eight major molecules are present in measurable proportions. A total of terpenes above 0.51 TP3T in a 101 TP3T CBD oil indicates good retention of the profile during the extraction process. Oils with a total below 0.11 TP3T are optionally full-spectrum, in practice closer to an isolate enriched with traces of terpenes.

The COA from a reputable CBD manufacturer includes a terpene profile with percentages of 8-15 main molecules. The total terpenes in good quality herb are 1-41 TP3T by weight, while in full-spectrum CBD oil they exceed 0.51 TP3T. The lack of a full-spectrum terpene declaration is a signal of limited transparency (Sommano et al., 2020).

Frequently Asked Questions About Terpenes in Marijuana

What are terpenes in marijuana and how are they produced?

Terpenes in marijuana are volatile isoprenoids from the monoterpene (C10H16) and sesquiterpene (C15H24) groups. They are produced in the glandular trichomes of the cannabis inflorescence from the precursors geranyl diphosphate (GPP) and farnesyl diphosphate (FPP). Cannabis sativa produces over 200 different terpenes, but 8-10 dominate the sensory and pharmacological profile (Booth & Bohlmann, Plant Science, 2019).

How are terpenes different from terpenoids?

Terpenes are pure hydrocarbons composed of isoprene units (C5H8). Terpenoids are their oxidized or chemically modified derivatives, containing additional oxygen, nitrogen, or other functional groups. After decarboxylation and drying of cannabis, some terpenes are converted into terpenoids with a slightly different pharmacological profile (Sommano et al., Molecules, 2020).

What is the entourage effect described by Russo in 2011?

The entourage effect is a synergy of cannabinoids (THC, CBD, CBG, CBC) and cannabis terpenes, described in a review by Ethan Russo in the British Journal of Pharmacology in 2011. Terpenes modulate the pharmacokinetics of THC and CBD, affect the blood-brain barrier, and bind to GABA, serotonin, and opioid receptors. Russo is cited in over 2,700 publications (Russo, Br J Pharmacol, 2011).

Which terpene in marijuana has anti-inflammatory properties?

Beta-caryophyllene has the strongest documented anti-inflammatory activity among cannabis terpenes. Gertsch et al. in 2008 in PNAS showed that it is a selective agonist of the CB2 receptor of the endocannabinoid system, making it a dietary cannabinoid. It is found in black pepper and cloves. It constitutes 1-15% of the cannabis terpene fraction (Gertsch et al., PNAS, 2008).

How do terpenes affect pain management, anxiety and sleep?

Myrcene and caryophyllene support the analgesic effects of THC and CBD through the CB2 receptor and GABA mechanisms. Linalool and limonene have documented anxiolytic effects in aromatherapy and animal models. Myrcene with linalool facilitates sleep. Russo 2011 compiled data for each terpene and specific clinical indications, although most studies come from animal models (Russo, Br J Pharmacol, 2011).

What is chemovar and how does it classify cannabis?

Chemovar is a classification of cannabis based on its chemical profile, not morphology. Lewis et al. in 2018 in Molecules distinguished three main types: Type I THC dominant (above 0.5%, CBD below 0.5%), Type II balanced (1:1), and Type III CBD dominant (above 0.5%, THC below 0.5%). The terpene profile complements this classification (Lewis et al., Molecules, 2018).

Do terpenes in aromatherapy work the same way as in marijuana?

Terpene molecules are chemically identical, regardless of the plant source. Linalool from lavender and linalool from hemp are the same molecule. The difference lies in the context. In hemp, terpenes co-occur with cannabinoids, which enhances the entourage effect. In aromatherapy, they work alone or in blends of plant essential oils (Sommano et al., Molecules, 2020).

How to read a COA for terpene profile?

A reputable manufacturer's COA includes a Terpene Profile section with percentages of 8-15 major terpenes (myrcene, limonene, pinene, linalool, caryophyllene, humulene, terpinolene, ocimene). The total terpenes in good weed is 1-4% by weight. The absence of a terpene profile in a full-spectrum COA is a signal of caution (Sommano et al., Molecules, 2020).

Are terpenes in Polish CBD legal?

Yes. Terpenes themselves are not regulated by the Act on Counteracting Drug Addiction. In Poland, CBD herbs and oils with a THC content below 0.31 TP3T, while maintaining a full terpene profile, are legal. In the 2018 WHO ECDD review, the safety and low addiction potential of CBD were confirmed (WHO ECDD, 2018).

Does myrcene from mango enhance the effects of hemp terpenes?

The hypothesis that mango eaten 30 minutes before cannabis enhances the effect of myrcene is popular, but it has not been confirmed in randomized human studies. Myrcene in mango has a concentration of 0.1-0.3%, in cannabis it is often 1-3%. Theoretical additivity exists, but the subjective effect may result from other psychophysiological factors (Sommano et al., Molecules, 2020).

Summary: Terpenes are chemistry, not magic.

Terpenes in marijuana are not just an aromatic additive, but an active pharmacological component that determines a significant portion of cannabis's therapeutic effects. Eight main molecules (myrcene, caryophyllene, limonene, pinene, linalool, humulene, terpinolene, and ocimene) and lesser-known ones like biscaplane create the unique profile of each strain. Russo (2011) demonstrated that without terpenes, the picture of cannabis pharmacology is incomplete.

For the informed CBD consumer in 2026, this means choosing full-spectrum or broad-spectrum products with a declared terpene profile. CBD isolates have their place, but they lose their entourage effect. The chemovar system (Lewis 2018) and GC-MS analysis of the terpene profile are the foundation of an informed purchase, based on chemistry, not marketing.

The Polish CBD market is maturing in terms of analytical transparency. More and more producers are publishing full COAs with terpene profiles, but there's still room for improvement. Consumers asking about terpene profiles in stores is a force that's changing the market. This is worth knowing and worth asking about every time you buy a CBD product.

Remember that terpenes in hemp are the same chemistry as those in lavender, hops, pepper, or lemon. Hemp isn't exotic, but rather unique due to the coexistence of terpenes with cannabinoids. Combining aromatherapy, dietary sources of terpenes (pepper, mango, hops), and full-spectrum CBD is a philosophy of a broader entourage effect, based on the botanical and chemical coherence of medicinal plants.

This article is for informational, educational, and scientific purposes only and does not constitute medical advice. In Poland, cannabis containing THC above 0.31 TP3T remains illegal under the Act on Counteracting Drug Addiction of July 29, 2005. CBD dried herbs and extracts with THC content below 0.31 TP3T, while maintaining a full terpene profile, are legal. Medical marijuana with higher THC is only available with a prescription from a licensed physician. Consult a physician before using CBD or other cannabinoids for therapeutic purposes, especially if you are taking other medications, are pregnant, or are breastfeeding.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: September 27, 2025
Last update: April 25, 2026